The Vermont Breast Cancer Surveillance System (BVCSS) proposes to continue membership in the Breast Cancer Surveillance Consortium (BCSC). As the most rural state in the nation, Vermont is well suited to complement more urban sites currently represented in the NCI Consortium. Our goal is to have our Vermont multi- disciplinary team of researchers join with other investigators at other BCSC sites and the NCI staff to conduct collaborative breast cancer surveillance research.
Our aims for the core proposal are: a) to maintain and improve a comprehensive, quality controlled, statewide surveillance system that accesses existing records and collects new information from mammography facilities, pathology laboratories, and a population-based cancer registry; b) to continue and expand breast cancer research collaborations and interactions among basic science researchers, clinical researchers and applied researchers in Vermont and in the NCI Breast Cancer Surveillance Consortium; c) to examine the operational aspects of breast cancer screening and diagnosis by conducting systematic research designed to assess the effectiveness and efficiency of screening programs and diagnostic techniques as they relate to the improvement of stage at diagnosis and breast cancer mortality. The two special research projects are focused on the use of additional imaging beyond the standard four-view screening mammogram. In project 1 we will determine the diagnostic accuracy of using either additional mammographic views and/or ultrasound compared with the standard four-view mammogram. In project 2 we will establish the psychological, social and behavioral effects of being recalled for additional imaging.
|Bodelon, Clara; Oh, Hannah; Chatterjee, Nilanjan et al. (2017) Association between breast cancer genetic susceptibility variants and terminal duct lobular unit involution of the breast. Int J Cancer 140:825-832|
|Geller, Berta M; Nelson, Heidi D; Weaver, Donald L et al. (2017) Characteristics associated with requests by pathologists for second opinions on breast biopsies. J Clin Pathol 70:947-953|
|Onega, Tracy; Weaver, Donald L; Frederick, Paul D et al. (2017) The diagnostic challenge of low-grade ductal carcinoma in situ. Eur J Cancer 80:39-47|
|Miglioretti, Diana L; Ichikawa, Laura; Smith, Robert A et al. (2017) Correlation Between Screening Mammography Interpretive Performance on a Test Set and Performance in Clinical Practice. Acad Radiol 24:1256-1264|
|Frederick, Paul D; Nelson, Heidi D; Carney, Patricia A et al. (2017) The Influence of Disease Severity of Preceding Clinical Cases on Pathologists' Medical Decision Making. Med Decis Making 37:91-100|
|Horne, Hisani N; Sherman, Mark E; Pfeiffer, Ruth M et al. (2016) Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease. Breast Cancer Res 18:24|
|Fenton, Joshua J; Onega, Tracy; Zhu, Weiwei et al. (2016) Validation of a Medicare Claims-based Algorithm for Identifying Breast Cancers Detected at Screening Mammography. Med Care 54:e15-22|
|Elmore, Joann G; Nelson, Heidi D; Pepe, Margaret S et al. (2016) Variability in Pathologists' Interpretations of Individual Breast Biopsy Slides: A Population Perspective. Ann Intern Med 164:649-55|
|Oh, Hannah; Bodelon, Clara; Palakal, Maya et al. (2016) Ages at menarche- and menopause-related genetic variants in relation to terminal duct lobular unit involution in normal breast tissue. Breast Cancer Res Treat 158:341-50|
|Carney, Patricia A; Allison, Kimberly H; Oster, Natalia V et al. (2016) Identifying and processing the gap between perceived and actual agreement in breast pathology interpretation. Mod Pathol 29:717-26|
Showing the most recent 10 out of 184 publications